NASDAQ

NewAmsterdam Pharma Company N.V. - Warrant (NAMSW)

♥ 643 Thanks from members

Community market perspectives and discussion for NewAmsterdam Pharma Company N.V. - Warrant (NASDAQ: NAMSW).

No chart available for this instrument.

Member Opinions and Insights

Special Briefing

How to Live for 300 Years: The Longevity Sandbox

Explore plasma cleansing, somatic organ swaps, and BCI.

Explore →
Entity and Market Metadata
Sector: HealthcareIndustry: BiotechnologyFounder: Dr. Michiel SustainableFounder: Bavarian Nordic teamLeadership: Marc de Garidel (CEO)Leadership: Konstantin Petropoulos (CFO)Holder: Fidelity Management and ResearchHolder: ForbionHolder: Cowen Healthcare InvestmentsObicetrapibCompany Warrants#NAMSW#NewAmsterdam Pharma#NASDAQ warrants#biotech stock#lipid-lowering therapy